This study will evaluate the RESET self-stigma reduction intervention: a face to face group workshop for PLHIV in the Netherlands that aims to reduce HIV-related self-stigma and improve wellbeing, specifically quality of life, self-esteem, resilient…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
hiv stigma en psychosociale gezondheid
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Primary outcomes of the RCT are the Berger HIV Stigma Scale (HSS), the World
Health Organization Quality of Life questionnaire (WHOQOL-BREF), the Rosenberg
Self Esteem Scale (RSES), the Empowerment Scale Rogers (ESR), and the Brief
Resilient Coping Scale (BRCS). The HSS, WHOQOL-BREF, RSES, ESR, BRCS will be
administered at baseline, post intervention and at three-month (post
intervention) follow up.
Secondary outcome
-
Background summary
HIV-related self-stigma is a significant barrier to an effective HIV response.
High levels of self-stigma have been associated with reduced health outcomes,
quality of life and access to HIV care and treatment for people living with HIV
(PLHIV) worldwide. Programs that effectively target self-stigma among PLHIV
remain scarce.
Study objective
This study will evaluate the RESET self-stigma reduction intervention: a face
to face group workshop for PLHIV in the Netherlands that aims to reduce
HIV-related self-stigma and improve wellbeing, specifically quality of life,
self-esteem, resilient coping, and personal empowerment of PLHIV.
Study design
A randomised clinical trial (RCT) will be performed consisting of one
intervention group and one (waiting list) control group. Randomization will be
done on the level of the individual.
Intervention
Face to face intervention workshop of 3 weeks with a weekly session of 2 hours.
PLHIV in both the intervention and waiting list control group will be able to
participate in the intervention, with participants in the control group
enrolling after the 3 months follow up measurement of the intervention group.
Study burden and risks
To the best of our knowledge, there are no risks associated with participating
in the face to face intervention workshop.
Valkenburgerweg 177
Heerlen 6419AT
NL
Valkenburgerweg 177
Heerlen 6419AT
NL
Listed location countries
Age
Inclusion criteria
a) having a diagnosis of HIV; b) being 18 years or older; c) being enrolled in
HIV care in the Netherlands; d) able to speak Dutch or English.
Exclusion criteria
Subjects with a serious medical, psychiatric or cognitive disease that would
interfere with participation (e.g. severe clinical depression with risk of
suicide or people with a serious drug or alcohol problem).
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL75259.100.20 |